AMPX
EROC
CC
IEX

Livingston Satterthwaite

Known title: DirectorCIK: 0001517394

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 14, 2026

Amprius Technologies Announces Shelf Registration and New Coverage. Amprius Technologies (AMPX) has filed a shelf registration, indicating plans for a potential new share offering. Canaccord Genuity has begun coverage with a positive rating and set a $14 price target, while analysts maintain an average target of $23. The company’s focus on advanced battery technology has been highlighted in recent commentary, underscoring its role in the evolving energy storage market.

this person other insiders at AMPX

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 12, 2026

ERock Gains on Supply Deal and AI Surge. ERock announced a multi‑year supply agreement with HD Construction Equipment to increase engine long‑block production, adding to its backlog. The company’s service component from current orders may support its valuation. The announcement coincided with a 10% jump in the stock driven by broader AI enthusiasm.

this person other insiders at EROC

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 12, 2026

Chemours Q2 Earnings Call and UBS Price Target Cut. Chemours released its Q2 2026 earnings call transcript, providing details on its financial performance. UBS kept a neutral stance but lowered its price target to $16, reflecting a more cautious view of the company's outlook. The new target sits below the current average analyst target of $18.22 and near the support level of $15.07, indicating a potential short‑term pressure on the stock.

this person other insiders at CC

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

IDEX price target raised to $285 by RBC Capital. RBC Capital has kept its outperform rating on IDEX and lifted the target price to $285, reflecting confidence in the company's earnings outlook. The move comes as the stock trades near the upper end of its 52‑week range and shows a moderately strong RSI of 63.3. Analysts see the firm’s valuation as still attractive compared to peers. The update may influence how investors view IDEX’s growth prospects.

this person other insiders at IEX

Transaction History

AMPX▲ Buy$0
EROC▲ Buy$0
CC▲ Buy$0
AMPX▲ Buy$0
CC▲ Buy$0
AMPX▲ Buy$0
CC▲ Buy$0
IEX▲ Buy$0
IEX▲ Buy$0
IEX▲ Buy$155K
IEX▼ Sell$685K
IEX▲ Buy$0
IEX▲ Buy$151K
IEX▼ Sell$831K

We use analytics to understand how market-wall is used. No personal data is sold.